HALO logo
halo search icon
Replimune Group, Inc.

US$5.16

Price Change Indicator
0.46 (9.79%)
Replimune Group, Inc.
REPL · NAS

Replimune Group, Inc.

Start Trading REPL for Free

US$5.16

Price Arrow0.46 (9.79%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig Candle (Realtime)Consensus ExpensiveHALO AllHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Replimune Group, Inc. Overview

REPL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About REPL

icon
icon

Telephone

1.781.222.9600

icon

Address

3rd Floor, Suite 303, 500 Unicorn Park Drive, Woburn, MA 01801

Description

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

REPL Price Chart

Key Stats

Market Cap

US$388.09M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.5 - 13.24

Trade Value (12mth)

US$7,916,210.00

1 week

-9.96%

1 month

152.69%

YTD

-47.19%

1 year

-44.44%

All time high

54.85

Key Fundamentals

EPS 3 yr Growth

2.50%

EBITDA Margin

NaN%

Operating Cashflow

-$157m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

-91.50

Quick Ratio

0.00

Other Data

Shares Outstanding (Fully Diluted)

92m

HALO Sector

Healthcare

Next Company Report Date

20-May-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

REPL Announcements

Latest Announcements

DateAnnouncements
13 April 26
04 April 26
04 February 26
04 February 26
04 February 26

REPL Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-3.24-3.07-3.07locklocklock
EPS (Fully Diluted)
 $locklocklocklock-3.24-3.07N/Alocklocklock
Growth
 %locklocklocklock-8.35.3N/Alocklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Replimune Group, Inc. (REPL:NAS)?
Halo FAQ
The current share price of Replimune Group, Inc. (REPL:NAS) is USD$5.16.
What is the 52-week high share price for Replimune Group, Inc. (REPL:NAS)?
Halo FAQ
The 52-week high share price for Replimune Group, Inc. (REPL:NAS) is USD$13.24.
What is the 52-week low share price for Replimune Group, Inc. (REPL:NAS)?
Halo FAQ
The 52-week low share price for Replimune Group, Inc. (REPL:NAS) is USD$1.50.
What is the dividend yield for Replimune Group, Inc. (REPL:NAS)?
Halo FAQ
Replimune Group, Inc. (REPL:NAS) does not pay a dividend.
What was Replimune Group, Inc. (REPL:NAS) last dividend payment?
Halo FAQ
Replimune Group, Inc. (REPL:NAS) does not pay a dividend.
What is the franking level for Replimune Group, Inc. (REPL:NAS)?
Halo FAQ
Replimune Group, Inc. (REPL:NAS) has a franking level of 0.00%.
In which sector is Replimune Group, Inc. (REPL:NAS) classified?
Halo FAQ
Replimune Group, Inc. (REPL:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial